Myoseverin B is a new microtubule-binding molecule which acts reversibly on myoblast proliferation without the cytotoxic effects displayed by nonpurine-based microtubule-disrupting molecules, like taxol, vinblastine, nocodazole. It can be effectively used for inhibiting endothelial cell function and differentiation of progenitor cells.
